Summary

The global market for Pharmaceutical Primary Inner Packaging was estimated to be worth US$ 41255 million in 2024 and is forecast to a readjusted size of US$ 59938 million by 2031 with a CAGR of 5.4% during the forecast period 2025-2031.
Pharmaceutical Primary Inner Packaging refers to the materials and containers that come into direct contact with the pharmaceutical product (such as drugs, vaccines, or other medical products). This packaging is designed to protect the product from external factors like contamination, moisture, light, air, and physical damage while also ensuring that the product maintains its efficacy, stability, and safety throughout its shelf life.
In recent years, the global Pharmaceutical Primary Inner Packaging market has maintained steady growth, mainly driven by the expansion of the biopharmaceutical industry, the acceleration of innovative drug research and development, and the rising demand for generic drugs. Among them, prefilled syringes (PFS), vials, ampoules and blister packaging dominate, while biodegradable materials and smart packaging have become emerging trends.
The core demand for Pharmaceutical Primary Inner Packaging comes from injections, biologics and oral solid preparations, especially the rise of biopharmaceuticals such as monoclonal antibodies and mRNA vaccines, which has driven the demand for high-barrier and low-adsorption packaging materials. In addition, the trend of personalized medicine and home medication has led to the growth of the market for small-dose packaging (such as single-dose eye drops and prefilled injection pens).
Regionally:
The United States, with its strong biopharmaceutical industry and strict FDA regulations, is driving demand for high-end primary packaging materials (such as sterile syringes and specialty polymer bottles). The European market is mature, and high-value-added drugs in countries such as Germany and Switzerland rely on high-specification glass bottles and rubber seals. The EU's sustainable development regulations (such as SUPD) promote the application of recyclable aluminum-plastic composite films and bio-based plastics. The Asia-Pacific region has the fastest growth. China and India have benefited from the export of generic drugs and the rise of local innovative drugs, and the demand for glass ampoules and plastic films has surged. Due to the aging society in Japan, the market potential for convenient packaging (such as tear-off aluminum foil) is huge.
Market development opportunities:
Monoclonal antibodies, cell therapies, etc. require ultra-low adsorption packaging materials, giving rise to customized solutions. The EU's "Green Deal" and FDA's recyclability guidelines have driven companies to develop biodegradable packaging materials. Internet of Things (IoT) integration (such as temperature recording labels) improves drug traceability, especially for cold chain-dependent vaccines. GMP certification upgrades in Southeast Asia (such as Indonesia and Vietnam) provide new growth points for packaging material suppliers.
Market risks and challenges:
Raw material fluctuations: Borosilicate glass is dependent on natural gas energy (European energy crisis exacerbates cost pressure). Regulatory barriers: USP＜660＞ and EU EP have stricter requirements on extractables/leachables (E&L), and the compliance costs of small and medium-sized enterprises are rising. Substitution threats: Packaging-free technologies (such as freeze-dried oral tablets) may reduce the demand for traditional packaging.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Primary Inner Packaging, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Pharmaceutical Primary Inner Packaging by region & country, by Type, and by Application.
The Pharmaceutical Primary Inner Packaging market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Primary Inner Packaging.
Market Segmentation
By Company
West Pharmaceutical Services
Gerresheimer
AptarGroup
Stevanato Group
Amcor
Shandong Pharmaceutical
Constantia Flexibles
Schott Pharma
Berry Global
SGD Pharma
Nipro
Shandong Weigao Group
BD
HySum
Chengdu Jingu Pharma-Pack Co.,Ltd
Chongqing Zhengchuan Pharmaceutical Packaging Co., Ltd
Gerresheimer Shuangfeng
Jinghua Group
Linuo Pharmaceutical Packaging
Jiyuan Zhengyu
EHUA
Segment by Type
Glass Packaging
Plastic Packaging
Metal Packaging
Segment by Application
Biopharmaceuticals
Chemical Pharmaceuticals
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Pharmaceutical Primary Inner Packaging company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Pharmaceutical Primary Inner Packaging in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Pharmaceutical Primary Inner Packaging in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

ページTOPに戻る

Table of Contents

1 Market Overview
1.1 Pharmaceutical Primary Inner Packaging Product Introduction
1.2 Global Pharmaceutical Primary Inner Packaging Market Size Forecast (2020-2031)
1.3 Pharmaceutical Primary Inner Packaging Market Trends & Drivers
1.3.1 Pharmaceutical Primary Inner Packaging Industry Trends
1.3.2 Pharmaceutical Primary Inner Packaging Market Drivers & Opportunity
1.3.3 Pharmaceutical Primary Inner Packaging Market Challenges
1.3.4 Pharmaceutical Primary Inner Packaging Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Pharmaceutical Primary Inner Packaging Players Revenue Ranking (2024)
2.2 Global Pharmaceutical Primary Inner Packaging Revenue by Company (2020-2025)
2.3 Key Companies Pharmaceutical Primary Inner Packaging Manufacturing Base Distribution and Headquarters
2.4 Key Companies Pharmaceutical Primary Inner Packaging Product Offered
2.5 Key Companies Time to Begin Mass Production of Pharmaceutical Primary Inner Packaging
2.6 Pharmaceutical Primary Inner Packaging Market Competitive Analysis
2.6.1 Pharmaceutical Primary Inner Packaging Market Concentration Rate (2020-2025)
2.6.2 Global 5 and 10 Largest Companies by Pharmaceutical Primary Inner Packaging Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Primary Inner Packaging as of 2024)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Glass Packaging
3.1.2 Plastic Packaging
3.1.3 Metal Packaging
3.2 Global Pharmaceutical Primary Inner Packaging Sales Value by Type
3.2.1 Global Pharmaceutical Primary Inner Packaging Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Pharmaceutical Primary Inner Packaging Sales Value, by Type (2020-2031)
3.2.3 Global Pharmaceutical Primary Inner Packaging Sales Value, by Type (%) (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Biopharmaceuticals
4.1.2 Chemical Pharmaceuticals
4.2 Global Pharmaceutical Primary Inner Packaging Sales Value by Application
4.2.1 Global Pharmaceutical Primary Inner Packaging Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Pharmaceutical Primary Inner Packaging Sales Value, by Application (2020-2031)
4.2.3 Global Pharmaceutical Primary Inner Packaging Sales Value, by Application (%) (2020-2031)
5 Segmentation by Region
5.1 Global Pharmaceutical Primary Inner Packaging Sales Value by Region
5.1.1 Global Pharmaceutical Primary Inner Packaging Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Pharmaceutical Primary Inner Packaging Sales Value by Region (2020-2025)
5.1.3 Global Pharmaceutical Primary Inner Packaging Sales Value by Region (2026-2031)
5.1.4 Global Pharmaceutical Primary Inner Packaging Sales Value by Region (%), (2020-2031)
5.2 North America
5.2.1 North America Pharmaceutical Primary Inner Packaging Sales Value, 2020-2031
5.2.2 North America Pharmaceutical Primary Inner Packaging Sales Value by Country (%), 2024 VS 2031
5.3 Europe
5.3.1 Europe Pharmaceutical Primary Inner Packaging Sales Value, 2020-2031
5.3.2 Europe Pharmaceutical Primary Inner Packaging Sales Value by Country (%), 2024 VS 2031
5.4 Asia Pacific
5.4.1 Asia Pacific Pharmaceutical Primary Inner Packaging Sales Value, 2020-2031
5.4.2 Asia Pacific Pharmaceutical Primary Inner Packaging Sales Value by Region (%), 2024 VS 2031
5.5 South America
5.5.1 South America Pharmaceutical Primary Inner Packaging Sales Value, 2020-2031
5.5.2 South America Pharmaceutical Primary Inner Packaging Sales Value by Country (%), 2024 VS 2031
5.6 Middle East & Africa
5.6.1 Middle East & Africa Pharmaceutical Primary Inner Packaging Sales Value, 2020-2031
5.6.2 Middle East & Africa Pharmaceutical Primary Inner Packaging Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Pharmaceutical Primary Inner Packaging Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Pharmaceutical Primary Inner Packaging Sales Value, 2020-2031
6.3 United States
6.3.1 United States Pharmaceutical Primary Inner Packaging Sales Value, 2020-2031
6.3.2 United States Pharmaceutical Primary Inner Packaging Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Pharmaceutical Primary Inner Packaging Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Pharmaceutical Primary Inner Packaging Sales Value, 2020-2031
6.4.2 Europe Pharmaceutical Primary Inner Packaging Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Pharmaceutical Primary Inner Packaging Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Pharmaceutical Primary Inner Packaging Sales Value, 2020-2031
6.5.2 China Pharmaceutical Primary Inner Packaging Sales Value by Type (%), 2024 VS 2031
6.5.3 China Pharmaceutical Primary Inner Packaging Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Pharmaceutical Primary Inner Packaging Sales Value, 2020-2031
6.6.2 Japan Pharmaceutical Primary Inner Packaging Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Pharmaceutical Primary Inner Packaging Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Pharmaceutical Primary Inner Packaging Sales Value, 2020-2031
6.7.2 South Korea Pharmaceutical Primary Inner Packaging Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Pharmaceutical Primary Inner Packaging Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Pharmaceutical Primary Inner Packaging Sales Value, 2020-2031
6.8.2 Southeast Asia Pharmaceutical Primary Inner Packaging Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Pharmaceutical Primary Inner Packaging Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Pharmaceutical Primary Inner Packaging Sales Value, 2020-2031
6.9.2 India Pharmaceutical Primary Inner Packaging Sales Value by Type (%), 2024 VS 2031
6.9.3 India Pharmaceutical Primary Inner Packaging Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 West Pharmaceutical Services
7.1.1 West Pharmaceutical Services Profile
7.1.2 West Pharmaceutical Services Main Business
7.1.3 West Pharmaceutical Services Pharmaceutical Primary Inner Packaging Products, Services and Solutions
7.1.4 West Pharmaceutical Services Pharmaceutical Primary Inner Packaging Revenue (US$ Million) & (2020-2025)
7.1.5 West Pharmaceutical Services Recent Developments
7.2 Gerresheimer
7.2.1 Gerresheimer Profile
7.2.2 Gerresheimer Main Business
7.2.3 Gerresheimer Pharmaceutical Primary Inner Packaging Products, Services and Solutions
7.2.4 Gerresheimer Pharmaceutical Primary Inner Packaging Revenue (US$ Million) & (2020-2025)
7.2.5 Gerresheimer Recent Developments
7.3 AptarGroup
7.3.1 AptarGroup Profile
7.3.2 AptarGroup Main Business
7.3.3 AptarGroup Pharmaceutical Primary Inner Packaging Products, Services and Solutions
7.3.4 AptarGroup Pharmaceutical Primary Inner Packaging Revenue (US$ Million) & (2020-2025)
7.3.5 AptarGroup Recent Developments
7.4 Stevanato Group
7.4.1 Stevanato Group Profile
7.4.2 Stevanato Group Main Business
7.4.3 Stevanato Group Pharmaceutical Primary Inner Packaging Products, Services and Solutions
7.4.4 Stevanato Group Pharmaceutical Primary Inner Packaging Revenue (US$ Million) & (2020-2025)
7.4.5 Stevanato Group Recent Developments
7.5 Amcor
7.5.1 Amcor Profile
7.5.2 Amcor Main Business
7.5.3 Amcor Pharmaceutical Primary Inner Packaging Products, Services and Solutions
7.5.4 Amcor Pharmaceutical Primary Inner Packaging Revenue (US$ Million) & (2020-2025)
7.5.5 Amcor Recent Developments
7.6 Shandong Pharmaceutical
7.6.1 Shandong Pharmaceutical Profile
7.6.2 Shandong Pharmaceutical Main Business
7.6.3 Shandong Pharmaceutical Pharmaceutical Primary Inner Packaging Products, Services and Solutions
7.6.4 Shandong Pharmaceutical Pharmaceutical Primary Inner Packaging Revenue (US$ Million) & (2020-2025)
7.6.5 Shandong Pharmaceutical Recent Developments
7.7 Constantia Flexibles
7.7.1 Constantia Flexibles Profile
7.7.2 Constantia Flexibles Main Business
7.7.3 Constantia Flexibles Pharmaceutical Primary Inner Packaging Products, Services and Solutions
7.7.4 Constantia Flexibles Pharmaceutical Primary Inner Packaging Revenue (US$ Million) & (2020-2025)
7.7.5 Constantia Flexibles Recent Developments
7.8 Schott Pharma
7.8.1 Schott Pharma Profile
7.8.2 Schott Pharma Main Business
7.8.3 Schott Pharma Pharmaceutical Primary Inner Packaging Products, Services and Solutions
7.8.4 Schott Pharma Pharmaceutical Primary Inner Packaging Revenue (US$ Million) & (2020-2025)
7.8.5 Schott Pharma Recent Developments
7.9 Berry Global
7.9.1 Berry Global Profile
7.9.2 Berry Global Main Business
7.9.3 Berry Global Pharmaceutical Primary Inner Packaging Products, Services and Solutions
7.9.4 Berry Global Pharmaceutical Primary Inner Packaging Revenue (US$ Million) & (2020-2025)
7.9.5 Berry Global Recent Developments
7.10 SGD Pharma
7.10.1 SGD Pharma Profile
7.10.2 SGD Pharma Main Business
7.10.3 SGD Pharma Pharmaceutical Primary Inner Packaging Products, Services and Solutions
7.10.4 SGD Pharma Pharmaceutical Primary Inner Packaging Revenue (US$ Million) & (2020-2025)
7.10.5 SGD Pharma Recent Developments
7.11 Nipro
7.11.1 Nipro Profile
7.11.2 Nipro Main Business
7.11.3 Nipro Pharmaceutical Primary Inner Packaging Products, Services and Solutions
7.11.4 Nipro Pharmaceutical Primary Inner Packaging Revenue (US$ Million) & (2020-2025)
7.11.5 Nipro Recent Developments
7.12 Shandong Weigao Group
7.12.1 Shandong Weigao Group Profile
7.12.2 Shandong Weigao Group Main Business
7.12.3 Shandong Weigao Group Pharmaceutical Primary Inner Packaging Products, Services and Solutions
7.12.4 Shandong Weigao Group Pharmaceutical Primary Inner Packaging Revenue (US$ Million) & (2020-2025)
7.12.5 Shandong Weigao Group Recent Developments
7.13 BD
7.13.1 BD Profile
7.13.2 BD Main Business
7.13.3 BD Pharmaceutical Primary Inner Packaging Products, Services and Solutions
7.13.4 BD Pharmaceutical Primary Inner Packaging Revenue (US$ Million) & (2020-2025)
7.13.5 BD Recent Developments
7.14 HySum
7.14.1 HySum Profile
7.14.2 HySum Main Business
7.14.3 HySum Pharmaceutical Primary Inner Packaging Products, Services and Solutions
7.14.4 HySum Pharmaceutical Primary Inner Packaging Revenue (US$ Million) & (2020-2025)
7.14.5 HySum Recent Developments
7.15 Chengdu Jingu Pharma-Pack Co.,Ltd
7.15.1 Chengdu Jingu Pharma-Pack Co.,Ltd Profile
7.15.2 Chengdu Jingu Pharma-Pack Co.,Ltd Main Business
7.15.3 Chengdu Jingu Pharma-Pack Co.,Ltd Pharmaceutical Primary Inner Packaging Products, Services and Solutions
7.15.4 Chengdu Jingu Pharma-Pack Co.,Ltd Pharmaceutical Primary Inner Packaging Revenue (US$ Million) & (2020-2025)
7.15.5 Chengdu Jingu Pharma-Pack Co.,Ltd Recent Developments
7.16 Chongqing Zhengchuan Pharmaceutical Packaging Co., Ltd
7.16.1 Chongqing Zhengchuan Pharmaceutical Packaging Co., Ltd Profile
7.16.2 Chongqing Zhengchuan Pharmaceutical Packaging Co., Ltd Main Business
7.16.3 Chongqing Zhengchuan Pharmaceutical Packaging Co., Ltd Pharmaceutical Primary Inner Packaging Products, Services and Solutions
7.16.4 Chongqing Zhengchuan Pharmaceutical Packaging Co., Ltd Pharmaceutical Primary Inner Packaging Revenue (US$ Million) & (2020-2025)
7.16.5 Chongqing Zhengchuan Pharmaceutical Packaging Co., Ltd Recent Developments
7.17 Gerresheimer Shuangfeng
7.17.1 Gerresheimer Shuangfeng Profile
7.17.2 Gerresheimer Shuangfeng Main Business
7.17.3 Gerresheimer Shuangfeng Pharmaceutical Primary Inner Packaging Products, Services and Solutions
7.17.4 Gerresheimer Shuangfeng Pharmaceutical Primary Inner Packaging Revenue (US$ Million) & (2020-2025)
7.17.5 Gerresheimer Shuangfeng Recent Developments
7.18 Jinghua Group
7.18.1 Jinghua Group Profile
7.18.2 Jinghua Group Main Business
7.18.3 Jinghua Group Pharmaceutical Primary Inner Packaging Products, Services and Solutions
7.18.4 Jinghua Group Pharmaceutical Primary Inner Packaging Revenue (US$ Million) & (2020-2025)
7.18.5 Jinghua Group Recent Developments
7.19 Linuo Pharmaceutical Packaging
7.19.1 Linuo Pharmaceutical Packaging Profile
7.19.2 Linuo Pharmaceutical Packaging Main Business
7.19.3 Linuo Pharmaceutical Packaging Pharmaceutical Primary Inner Packaging Products, Services and Solutions
7.19.4 Linuo Pharmaceutical Packaging Pharmaceutical Primary Inner Packaging Revenue (US$ Million) & (2020-2025)
7.19.5 Linuo Pharmaceutical Packaging Recent Developments
7.20 Jiyuan Zhengyu
7.20.1 Jiyuan Zhengyu Profile
7.20.2 Jiyuan Zhengyu Main Business
7.20.3 Jiyuan Zhengyu Pharmaceutical Primary Inner Packaging Products, Services and Solutions
7.20.4 Jiyuan Zhengyu Pharmaceutical Primary Inner Packaging Revenue (US$ Million) & (2020-2025)
7.20.5 Jiyuan Zhengyu Recent Developments
7.21 EHUA
7.21.1 EHUA Profile
7.21.2 EHUA Main Business
7.21.3 EHUA Pharmaceutical Primary Inner Packaging Products, Services and Solutions
7.21.4 EHUA Pharmaceutical Primary Inner Packaging Revenue (US$ Million) & (2020-2025)
7.21.5 EHUA Recent Developments
8 Industry Chain Analysis
8.1 Pharmaceutical Primary Inner Packaging Industrial Chain
8.2 Pharmaceutical Primary Inner Packaging Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Pharmaceutical Primary Inner Packaging Sales Model
8.5.2 Sales Channel
8.5.3 Pharmaceutical Primary Inner Packaging Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer